Unknown

Dataset Information

0

Sizing nanomaterials in bio-fluids by cFRAP enables protein aggregation measurements and diagnosis of bio-barrier permeability.


ABSTRACT: Sizing nanomaterials in complex biological fluids, such as blood, remains a great challenge in spite of its importance for a wide range of biomedical applications. In drug delivery, for instance, it is essential that aggregation of protein-based drugs is avoided as it may alter their efficacy or elicit immune responses. Similarly it is of interest to determine which size of molecules can pass through biological barriers in vivo to diagnose pathologies, such as sepsis. Here, we report on continuous fluorescence recovery after photobleaching (cFRAP) as a analytical method enabling size distribution measurements of nanomaterials (1-100?nm) in undiluted biological fluids. We demonstrate that cFRAP allows to measure protein aggregation in human serum and to determine the permeability of intestinal and vascular barriers in vivo. cFRAP is a new analytical technique that paves the way towards exciting new applications that benefit from nanomaterial sizing in bio-fluids.

SUBMITTER: Xiong R 

PROVIDER: S-EPMC5036146 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sizing nanomaterials in bio-fluids by cFRAP enables protein aggregation measurements and diagnosis of bio-barrier permeability.

Xiong Ranhua R   Vandenbroucke Roosmarijn E RE   Broos Katleen K   Brans Toon T   Van Wonterghem Elien E   Libert Claude C   Demeester Jo J   De Smedt Stefaan C SC   Braeckmans Kevin K  

Nature communications 20160922


Sizing nanomaterials in complex biological fluids, such as blood, remains a great challenge in spite of its importance for a wide range of biomedical applications. In drug delivery, for instance, it is essential that aggregation of protein-based drugs is avoided as it may alter their efficacy or elicit immune responses. Similarly it is of interest to determine which size of molecules can pass through biological barriers in vivo to diagnose pathologies, such as sepsis. Here, we report on continuo  ...[more]

Similar Datasets

| S-EPMC4529363 | biostudies-other
| S-EPMC6168465 | biostudies-literature
| S-EPMC3921072 | biostudies-literature
| S-EPMC9312486 | biostudies-literature
| S-EPMC4000788 | biostudies-other
| S-EPMC6727651 | biostudies-literature
| S-EPMC8664268 | biostudies-literature
| S-EPMC6904566 | biostudies-literature
| S-EPMC6107575 | biostudies-literature
| S-EPMC7606840 | biostudies-literature